Krishna Institute of Medical Sciences Limited was listed on the BSE and NSE on June 28, 2021. Since its listing, its stock has delivered an impressive return of over 200%. Will it continue to offer such massive returns this year and in the future as well? In this article, we will explore the KIMS growth potential and the KIMS share price target 2025 to 2050.
About KIMS Ltd.
Krishna Institute of Medical Sciences (KIMS) Ltd. is one of India’s leading healthcare providers, offering high-quality medical services through its network of multi-specialty hospitals. Established in 2000 by Dr. Bhaskar Rao, a renowned cardiothoracic surgeon, KIMS focuses on delivering advanced medical care across various specialties, including cardiology, oncology, neurology, orthopedics, and more.
KIMS Ltd. Fundamental Analysis
| Stock Name | KIMS Ltd. |
|---|---|
| NSE Symbol | KIMS |
| Market Cap | ₹ 26283 Cr. |
| 52W High | ₹ 708 |
| 52W Low | ₹ 350 |
| Stock P/E (TTM) | 75.5 |
| Book Value | ₹50 |
| Dividend Yield | 0 % |
| ROCE | 16.9 % |
| ROE | 17.6 % |
| Face Value | ₹ 2 |
| Industry PE52.9 | 2.9 |
| Price to book value | 13.1 |
| Debt to equity | 0.89 |
| PEG Ratio | 1.42 |
| Quick ratio | 0.87 |
| Shareholder | March 2023 | March 2024 | March 2025 |
|---|---|---|---|
| Promoters | 38.85% | 38.82% | 38.82% |
| FIIs | 19.41% | 16.73% | 15.44% |
| DIIs | 29.76% | 33.13% | 31.95% |
| Public | 11.99% | 11.32% | 13.78% |
| No. of Shareholders | 60,980 | 69,092 | 1,01,895 |
Pros of Investing in KIMS Ltd.
- Strong Market Presence: KIMS Ltd. is one of the largest hospital chains in South India, with a network of multi-specialty hospitals providing high-quality healthcare services.
- Consistent Revenue Growth: KIMS’ sales have grown at 22% CAGR over the last 5 years.
- Consistent Profit Growth: KIMS’ profits have grown at 53% CAGR over the last 5 years.
- High Return on Capital Employed (ROCE): KIMS’ 5yrs average ROCE is 24.6%, which shows that it is utilizing its capital effectively to generate profits.
- High Return on Equity (ROE): KIMS’ 5-year average ROE is 22.6%, which shows that the company is using its shareholders’ funds well to generate profits.
- Growing Healthcare Demand: With India’s ageing population and rising rates of chronic disease, the healthcare sector has significant growth potential.
- Expansion Plans: The company is actively expanding its network through new hospitals and acquisitions in underserved areas, enhancing its market share and revenue base.
Cons of Investing in KIMS
- Regulatory Risks: The healthcare sector is highly regulated, and any changes in government policies, pricing caps, or compliance requirements could impact profitability.
- High Competition: KIMS faces competition from other large hospital chains such as Apollo Hospitals and Fortis Healthcare, which may limit its market share growth.
- Capital-Intensive Business: Expanding and maintaining hospital infrastructure requires significant investment, which can lead to high debt levels or reduced margins.
- Dependence on South India: A large portion of KIMS’s revenue comes from its South Indian operations, making it regionally concentrated and exposed to local market risks.
- Overvaluation Concern: KIMS’ stock is trading at a PE ratio of 76.7 and a (P/B) ratio of 13.3, which shows that its stock is significantly overvalued compared to its earnings and assets.
- Decrease in Institutional Confidence: DIIs have reduced their holding to 31.95% in March 2025 from 32.05% in December 2024 while FIIs have reduced their holding to 15.44% in March 2025 from 15.68% in December 2024, indicating a decline in institutional confidence in the company’s future growth prospects.
KIMS Ltd Balance Sheet
| Particulars | March 2023 | March 2024 | Sept 2024 |
|---|---|---|---|
| Equity Capital | 80 | 80 | 80 |
| Reserves | 1,590 | 1,748 | 1,922 |
| Borrowings | 678 | 1,355 | 1,782 |
| Other Liabilities | 553 | 636 | 794 |
| Total Liabilities | 2,901 | 3,820 | 4,579 |
| Fixed Assets | 1,766 | 2,434 | 2,632 |
| CWIP | 477 | 600 | 854 |
| Investments | 68 | 157 | 90 |
| Other Assets | 590 | 629 | 1,002 |
| Total Assets | 2,901 | 3,820 | 4,579 |
By the end of 2025, the KIMS share price is expected to be around ₹880 in normal conditions. In a bear market, it might be ₹820, and in a bull market, it may go up to ₹1020.
| KIMS Share Price Target 2025 | Rupees (₹) |
|---|---|
| 1st Target | 820 |
| 2nd Target | 880 |
| 3rd Target | 1020 |
In 2026, the KIMS share price is expected to be around ₹1050 in a normal situation. In a bear market, it might be ₹980, and in a bull market, it may cross ₹1320.
| KIMS Share Price Target 2026 | Rupees (₹) |
|---|---|
| 1st Target | 980 |
| 2nd Target | 1050 |
| 3rd Target | 1320 |
According to our analysis, the KIMS share price is expected to be around ₹1350 in 2027. In a bear market, it might be ₹1180, and in a bull market, it may cross ₹1720.
| KIMS Share Price Target 2027 | Rupees (₹) |
|---|---|
| 1st Target | 1180 |
| 2nd Target | 1350 |
| 3rd Target | 1720 |
According to our analysis, the KIMS share price may trade near ₹1550 by 2028; bearish conditions could pull it down to ₹1410, while a strong bull run might lift it to ₹2240.
| KIMS Share Price Target 2028 | Rupees (₹) |
|---|---|
| 1st Target | 1410 |
| 2nd Target | 1550 |
| 3rd Target | 2240 |
In a normal situation, the KIMS share price is projected to be approximately ₹1900 in 2029. In a bear market, the value may be as low as ₹1700, while in a bull market, it may rise to ₹2910.
| KIMS Share Price Target 2029 | Rupees (₹) |
|---|---|
| 1st Target | 1700 |
| 2nd Target | 1900 |
| 3rd Target | 2910 |
By 2030, the KIMS share price is projected to be around ₹2250 under normal conditions. In adverse markets, the price could fall to ₹2050, while favorable conditions might push it up to ₹3800.
| KIMS Share Price Target 2030 | Rupees (₹) |
|---|---|
| 1st Target | 2050 |
| 2nd Target | 2250 |
| 3rd Target | 3800 |
By 2035, the KIMS share price is projected to be around ₹5500 under normal conditions. In adverse markets, the price could fall to ₹4100, while favorable conditions might push it up to ₹11300.
| KIMS Share Price Target 2035 | Rupees (₹) |
|---|---|
| 1st Target | 4100 |
| 2nd Target | 5500 |
| 3rd Target | 11300 |
Under normal conditions, the KIMS share price might hit ₹11000 by 2040. A bearish trend could lower it to ₹8150, whereas a bullish surge could raise it to ₹34000.
| KIMS Share Price Target 2040 | Rupees (₹) |
|---|---|
| 1st Target | 8150 |
| 2nd Target | 11000 |
| 3rd Target | 34000 |
In 2050, the KIMS share price is expected to be around ₹35500 in a normal situation. In a bear market, it might be ₹32640, and in a bull market, it may go up to ₹204510.
| KIMS Share Price Target 2050 | Rupees (₹) |
|---|---|
| 1st Target | 32,000 |
| 2nd Target | 35,500 |
| 3rd Target | 2,00,000 |
| Years | Target Price |
|---|---|
| KIMS Share Price Target 2025 | ₹820 to ₹1020 |
| KIMS Share Price Target 2026 | ₹980 to ₹1320 |
| KIMS Share Price Target 2027 | ₹1180 to ₹1720 |
| KIMS Share Price Target 2028 | ₹1410 to ₹2240 |
| KIMS Share Price Target 2029 | ₹1700 to ₹2910 |
| KIMS Share Price Target 2030 | ₹2050 to ₹3800 |
| KIMS Share Price Target 2035 | ₹4100 to ₹11,300 |
| KIMS Share Price Target 2040 | ₹8150 to ₹34,000 |
| KIMS Share Price Target 2050 | ₹32,000 to ₹2,00,000 |
Conclusion
KIMS has delivered impressive returns over the last three years and has strong growth potential. KIMS has the potential for long-term success. However, investors should consider factors like its high valuation, regional dependency on South India, and regulatory challenges.
Disclaimer
This article is for educational purposes only. It is not a stock recommendation and should not be treated as such. Please ask your financial advisor before making any investment decision.
